How much is Nutrien worth?
Novartis AG (NVS) is a major global pharmaceutical company, and as of the end of the trading session on July 24, 2026, its shares closed at a price of $155.01 per share on the New York Stock Exchange. The company’s total market capitalization is approximately $315.84 billion. Novartis is a key player in the healthcare industry, and its stock price is a reflection of investor confidence in its pharmaceutical pipeline, clinical trial progress, and overall financial stability. Investors tracking NVS look at various metrics, including its earnings per share, which were approximately $6.62, and its price-to-earnings ratio of about 23.41, to determine the value of the stock. As with any publicly traded security, the price of $155.01 is subject to change based on ongoing market activity, sector trends, and the company's future corporate performance.
Related FAQs
Natera, Inc.
Oakworth Capital Bank is a specialized regional commercial financial and wealth management institution maintaining total consolidated assets of approximately $1.9 billion.
nVent Electric plc operates as a global industrial technology leader that designs, manufactures, markets, and services high-performance electrical connection and protection products.
As of July 2026, Nutrien (NTR) is valued at a market capitalization of approximately ₹3.109 trillion.